Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder characterized by reproductive and metabolic disturbances. Androgen excess is a hallmark of PCOS, driving many of the phenotypic features. In 2020, several findings highlight altered metabolic pathways as an underlying biological mechanism in PCOS. These findings add to our understanding of the complex interaction between metabolic homeostasis and reproduction.
Key advances
-
Polycystic ovary syndrome (PCOS) has genetically distinct reproductive and metabolic subtypes4.
-
A polygenic risk score-based phenome-wide association study has identified shared biological pathways between PCOS and obesity5.
-
Both the brain and adipose tissue are key tissues in the development of androgen-induced reproductive dysfunction in a mouse model of PCOS7.
-
Intranasal insulin administration improves the reduced adaptive thermogenesis in a sheep model of PCOS8.
-
Unfavourable changes in the diversity and composition of the gut microbiome are already present in adolescents with PCOS, independent of obesity9.
-
Changes in the dietary macronutrient balance improve reproductive dysfunction in a mouse model of PCOS, without beneficial effects on metabolic dysfunction10.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Dumesic, D. A. et al. Scientific Statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome. Endocr. Rev. 36, 487–525 (2015).
Teede, H. J. et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum. Reprod. 33, 1602–1618 (2018).
Day, F. et al. Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria. PLoS Genet. 14, e1007813 (2018).
Dapas, M. et al. Distinct subtypes of polycystic ovary syndrome with novel genetic associations: An unsupervised, phenotypic clustering analysis. PLoS Med. 17, e1003132 (2020).
Joo, Y. Y. et al. A polygenic and phenotypic risk prediction for polycystic ovary syndrome evaluated by phenome-wide association studies. J. Clin. Endocrinol. Metab. 105, 1918–1936 (2020).
Caldwell, A. S. L. et al. Neuroendocrine androgen action is a key extraovarian mediator in the development of polycystic ovary syndrome. Proc. Natl Acad. Sci. USA 114, E3334–E3343 (2017).
Cox, M. J. et al. Androgen action in adipose tissue and the brain are key mediators in the development of PCOS traits in a mouse model. Endocrinology 161, bqaa061 (2020).
Siemienowicz, K. et al. Insights into manipulating postprandial energy expenditure to manage weight gain in polycystic ovary syndrome. iScience 23, 101164 (2020).
Jobira, B. et al. Obese adolescents with PCOS have altered biodiversity and relative abundance in gastrointestinal microbiota. J. Clin. Endocrinol. Metab. 105, e2134–e2144 (2020).
Rodriguez Paris, V. et al. Defining the impact of dietary macronutrient balance on PCOS traits. Nat. Commun. 11, 5262 (2020).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing interests.
Rights and permissions
About this article
Cite this article
Visser, J.A. The importance of metabolic dysfunction in polycystic ovary syndrome. Nat Rev Endocrinol 17, 77–78 (2021). https://doi.org/10.1038/s41574-020-00456-z
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41574-020-00456-z